Subscribe
Addressing the Need for New Drugs to Treat of Pediatric Cancers with Charles Keller, Scientific Director at the Children's Cancer Therapy Development Institute

Outcomes Rocket

Addressing the Need for New Drugs to Treat of Pediatric Cancers with Charles Keller, Scientific Director at the Children's Cancer Therapy Development Institute

June 23, 2021

Addressing the Need for New Drugs to Treat of Pediatric Cancers with Charles Keller, Scientific Director at the Children's Cancer Therapy Development Institute

In this episode, we have the privilege of hosting the amazing Dr. Charles Keller, Scientific Director at the Children’s Cancer Therapy Development Institute. The CCTDI is a 501C3 non-profit biotech that tries to both understand how cancers work, but also test and evaluate thoroughly the drugs that might hit a particular target to stop cancer from working. Dr. Charles shares how his team is helping facilitate the development of medication that works while also de-risking investment in the pharma space. He talks about the preclinical gap and shares anecdotal, challenges, setbacks, and more. Dr. Charles and his team are doing a wonderful job helping children with cancer. Learn more about CCTDI and how you can help in this episode.

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Proudly supported by:

cover
S1.Ep1: The promise of Personalised Health: Is this the Future of Healthcare? An introduction to the promise and potential of personalised health